Darunavir

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 6863 publications

Comparable efficacy of bictegravir/emtricitabine/tenofovir alafenamide and doravirine/lamivudine/tenofovir disoproxil fumarate in therapy-naive Human Immunodeficiency Virus adults with very high baseline viraemia.

Comparable efficacy of bictegravir/emtricitabine/tenofovir alafenamide and doravirine/lamivudine/tenofovir disoproxil fumarate in therapy-naive Human Immunodeficiency Virus adults with very high baseline viraemia.

Journal: Journal of medical microbiology

Published: April 10, 2026

Simian Immunodeficiency Virus and Antiretroviral Therapy Impact Rhesus Macaque Brain Lipid Distribution.

Simian Immunodeficiency Virus and Antiretroviral Therapy Impact Rhesus Macaque Brain Lipid Distribution.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Lenacapavir as pre-exposure prophylaxis for HIV prevention.

Lenacapavir as pre-exposure prophylaxis for HIV prevention.

Journal: The Cochrane database of systematic reviews

Published: April 01, 2026

Investigation of the effects of antivirals used in hepatitis B treatment on blood lipid profile: a retrospective real-life data analysis.

Investigation of the effects of antivirals used in hepatitis B treatment on blood lipid profile: a retrospective real-life data analysis.

Journal: Minerva gastroenterology

Published: March 18, 2026

Fracture risk assessment in patients prescribed pre-exposure prophylaxis for HIV: An audit and comparative evaluation of screening tools.

Fracture risk assessment in patients prescribed pre-exposure prophylaxis for HIV: An audit and comparative evaluation of screening tools.

Journal: International journal of STD & AIDS

Published: March 17, 2026

Atorvastatin suppresses HIV/antiretroviral drug-induced cardiac fibrosis and dysfunction in mice by blocking platelet TGFβ1 signaling.

Atorvastatin suppresses HIV/antiretroviral drug-induced cardiac fibrosis and dysfunction in mice by blocking platelet TGFβ1 signaling.

Journal: JCI insight

Published: March 03, 2026

Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial.

Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial.

Journal: The Pediatric infectious disease journal

Published: February 24, 2026

Large-scale sequencing study of de novo regulatory Tandem Repeats (TRs) identifies new ASD (Autism Spectrum Disorders) candidate genes integrating gene expression mapping, brain scRNA-seq and organoid models.

Large-scale sequencing study of de novo regulatory Tandem Repeats (TRs) identifies new ASD (Autism Spectrum Disorders) candidate genes integrating gene expression mapping, brain scRNA-seq and organoid models.

Journal: Research square

Published: February 23, 2026

Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-Identified Data From South Africa.

Risk of Major Adverse Cardiovascular Events With Dolutegravir Versus Efavirenz-Based Antiretroviral Therapy: Emulated Target Trials Using Routine, De-Identified Data From South Africa.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 13, 2026

Correction: Bhola et al. An Integrative Bioinformatics Approach to Investigating TIMP3 and Immune Cell Infiltration: Prognostic and Clinicopathological Implications. Int. J. Mol. Sci. 2025, 26, 8867.

Correction: Bhola et al. An Integrative Bioinformatics Approach to Investigating TIMP3 and Immune Cell Infiltration: Prognostic and Clinicopathological Implications. Int. J. Mol. Sci. 2025, 26, 8867.

Journal: International journal of molecular sciences

Published: February 06, 2026

Doravirine versus dolutegravir-based regimen in antiretroviral treatment-naive people living with HIV-1 (ANRS0392s ELDORADO): protocol for an international, open-label, randomised, non-inferiority, phase III trial.

Doravirine versus dolutegravir-based regimen in antiretroviral treatment-naive people living with HIV-1 (ANRS0392s ELDORADO): protocol for an international, open-label, randomised, non-inferiority, phase III trial.

Journal: BMJ open

Published: February 05, 2026

Corrigendum to "Systemic delivery of tenofovir alafenamide using dissolving and implantable microneedle patches" [Mater. Today Bio 13 (2022) 100217].

Corrigendum to "Systemic delivery of tenofovir alafenamide using dissolving and implantable microneedle patches" [Mater. Today Bio 13 (2022) 100217].

Journal: Materials today. Bio

Published: February 02, 2026

Showing 1-12 of 6,863

Last Updated: 04/28/2026